Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Neurobiology of Aging|November 19, 2013
Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognitionBrittany L Adler, Mark Yarchoan, Hae Min Hwang, et al.F1000 Medicine Reports|October 16, 2010
Treatment advances in Alzheimer's disease based on the oxidative stress modelAvi L Friedlich, Raj K Rolston, Xiongwei Zhu, et al.Brain Pathology (Zurich, Switzerland)|December 6, 2018
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer diseaseChunyu Wang, Fanpeng Zhao, Katie Shen, et al.Cell Death & Disease|March 17, 2017
Regulation of RhoA activity by the cellular prion proteinHee-Jun Kim, Hong-Seok Choi, Jeong-Ho Park, et al.Journal of Neurochemistry|July 31, 2013
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistanceDavid J Bonda, Jeremy G Stone, Sandy L Torres, et al.International Journal of Biomedical Science : IJBS|July 19, 2011
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer DiseaseTimothy A Clark, Hyun Pil Lee, Raj K Rolston, et al.Molecular Biology of the Cell|March 11, 2011
Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal deathKuei-Hua Chang, Parminder Singh Multani, Kai-Hui Sun, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's diseaseYi Hong, Chi Bun Chan, Il-Sun Kwon, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 5, 2011
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granulesRudy J Castellani, Yashi Gupta, Baiyang Sheng, et al.Biochimica Et Biophysica Acta|December 24, 2004
Tau modifiers as therapeutic targets for Alzheimer's diseaseQuan Liu, Hyoung-gon Lee, Kazuhiro Honda, et al.Pageof 14